Talphera (TLPH) Current Assets (2010 - 2026)
Talphera's (TLPH) quarterly Current Assets came in at $21.3 million in Q1 2026, up 245.47% year-on-year from $6.2 million in Q1 2025, and up 2.09% quarter-over-quarter from $20.9 million in Q4 2025.
Talphera (TLPH) Current Assets (2010 - 2026) Analysis & Trends
Talphera's Current Assets history runs 17 years deep, the most recent figure standing at $21.3 million for Q1 2026.
- On a quarterly basis, Current Assets rose 245.47% year-over-year to $21.3 million in Q1 2026; TTM through Mar 2026 was $21.3 million, a 245.47% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 121.94% from the prior year.
- Current Assets climbed to $21.3 million in Q1 2026 per TLPH's latest filing, from $20.9 million in the prior quarter.
- Across five years, Current Assets topped out at $42.8 million in Q1 2022 and bottomed at $6.2 million in Q1 2025.
- The 5-year median for Current Assets is $17.4 million (2023), against an average of $18.3 million.
- Across the five-year window, Current Assets tumbled 72.38% in 2023 and surged 245.47% in 2026, its largest moves.
- Year by year, Current Assets stood at $24.6 million in 2022, then plunged by 52.88% to $11.6 million in 2023, then declined by 18.65% to $9.4 million in 2024, then surged by 121.94% to $20.9 million in 2025, then rose by 2.09% to $21.3 million in 2026.
- Per Business Quant, the three latest TLPH Current Assets figures stand at $21.3 million (Q1 2026), $20.9 million (Q4 2025), and $21.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 21.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.34 Mn |
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 21.92 Mn |
| Jun 30, 2025 | 7.70 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 9.42 Mn |
| Sep 30, 2024 | 12.20 Mn |
| Jun 30, 2024 | 16.04 Mn |
| Mar 31, 2024 | 19.95 Mn |
| Dec 31, 2023 | 11.58 Mn |
| Sep 30, 2023 | 14.42 Mn |
| Jun 30, 2023 | 8.84 Mn |
| Mar 31, 2023 | 17.35 Mn |
| Dec 31, 2022 | 24.57 Mn |
| Sep 30, 2022 | 24.54 Mn |
| Jun 30, 2022 | 32.00 Mn |
| Mar 31, 2022 | 42.81 Mn |
| Dec 31, 2021 | 50.49 Mn |
| Sep 30, 2021 | 51.75 Mn |
| Jun 30, 2021 | 58.97 Mn |